Could a Nerve-Protecting vitamin pill boost vision recovery in blocked retina veins?
NCT ID NCT07133438
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether adding a nerve-protecting drug (mecobalamin) to standard anti-VEGF eye injections can improve vision and reduce the number of injections needed for people with retinal vein occlusion (RVO). About 120 adults with RVO will receive either mecobalamin or a placebo pill for 6 months, alongside their regular injections. The main goal is to see if the combination reduces retinal swelling and improves eyesight over one year.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RETINAL VEIN OCCLUSION (RVO) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
No. 1, Friendship Road, Yuanjiagang, Yuzhong District, Chongqing City
RECRUITINGChongqing, 400016, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.